This inventor holds 22 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: Scios Inc., Scios Nova, Inc., US Government as Represented by the Secretary of the Army. Active years: 1993-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Baltimore, MD (US) (1993 - 1997)
- Timonium, MD (US) (1997)
- Sunnyvale, CA (US) (1998 - 2009)
Company Filing History:
19 out of 82 
2 out of 40 
1 out of 8,748 
Years Active: 1993-2009
Areas of Expertise:
Title: Babu J Mavunkel: Pioneer of Innovative Pharmaceutical Patents
Introduction
Babu J Mavunkel, based in Sunnyvale, CA, is a prominent inventor in the pharmaceutical realm, known for his significant contributions to drug development. With an impressive portfolio of 22 patents, Mavunkel's work primarily focuses on innovative methods to inhibit critical kinases, a key target in therapeutic interventions.
Latest Patents
Mavunkel's latest inventions include two notable patents concerning indole-type derivatives as inhibitors of p38 kinase. The first patent focuses on methods to inhibit p38-α kinase using compounds that feature a phenyl or thienyl group connected through a piperidine or piperazine nucleus to an indole residue, mandatorily having a substituent on the ring nitrogen, which is either an amino or substituted amino group. The second patent also addresses methods for inhibiting p38-α kinase, but it utilizes compounds that contain an aromatic system linked through a 7-membered heterocycle to an indole-type system. These innovative approaches could potentially lead to significant advancements in treating various diseases.
Career Highlights
Throughout his career, Babu J Mavunkel has made substantial contributions to the fields he has worked in. He has been associated with Scios Inc. and Scios Nova, Inc., where his expertise in medicinal chemistry and drug development has played a pivotal role in advancing pharmaceutical innovations.
Collaborations
Mavunkel has collaborated with notable colleagues such as John J Perumattam and Sundeep Dugar. These partnerships have allowed him to enhance his research and explore new avenues in drug discovery, leading to groundbreaking inventions in the industry.
Conclusion
Babu J Mavunkel stands out as a leading inventor in pharmaceutical innovations, with a focus on inventive methods to combat diseases through inhibition of specific kinases. His contributions, marked by multiple patents and collaborative efforts, showcase his dedication to advancing medical science and improving therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile